中医药科技创新体系建设 整合优化是良方

2018-07-09 宋莉萍 健康报医生频道

科技创新是中医药振兴发展的重大战略方向,加快中医药科技创新体系建设,不仅是建设国家创新体系的重要内容,也是贯彻落实创新驱动发展国家战略、提高中医药创新能力的必然要求。为贯彻实施创新发展战略,在日前举办的珠江会议第27届学术研讨会上,相关领域的专家以“符合中医药特点的中医药科技创新体系建设战略部署”为主题展开讨论。


科技创新是中医药振兴发展的重大战略方向,加快中医药科技创新体系建设,不仅是建设国家创新体系的重要内容,也是贯彻落实创新驱动发展国家战略、提高中医药创新能力的必然要求。为贯彻实施创新发展战略,在日前举办的珠江会议第27届学术研讨会上,相关领域的专家以“符合中医药特点的中医药科技创新体系建设战略部署”为主题展开讨论。

创新基地有待进一步提升

中国中医科学院中药研究所杨洪军教授介绍,科技创新基地是开展科技创新活动的重要载体,加强国家科技创新基地资源整合和能力建设,是加快国家创新体系建设的重要内容。中国工程院院士黄璐琦牵头负责的《中医药科技创新体系建设》项目,通过政策研究、现状分析、问卷调查、调研座谈、专家咨询等研究方法,发现中医药科技创新基地领域及地区分布不均衡,呈现出药强医弱、产业强学科弱的现状。同时, 多元投入与绩效评估机制尚未建立,导致长效投入缺乏,高水平的学术、学科带头人不足,人才激励机制尚未建立。

针对以上问题,项目组建议:基地布局要有长远性和全局性,做好顶层设计,统筹国家、省部、行业相关基地,避免低水平、交叉和重复建设;优先在已有的国家重点实验室培育基地中,争取实现学科国家重点实验室突破;结合国家中医临床研究基地建设,加快推进中医类国家医学研究中心立项与建设;基地要兼顾地区及学科发展水平,向中西部、少数民族地区和相对弱势学科给予政策倾斜;推进平台间整合与协同创新,加强多学科协同创新及开放共享;人才为先,领军人才的培养与引进尤为迫切。

创新体系建设要分级分层

广州中医药大学陈蔚文教授认为,并非全世界的科技创新都适用于中医药创新研究的发展,尽量避免赶时髦。中医药创新要赢得业内外一致的好评及认可,只是自己拍手称赞还不行。此外,要加强统筹策划,战略布局充分考虑全国不同的区域特点和优势差别。

湖北省中医院院长涂远超指出,应建立符合中医药研究的评价体系。比如,以中国中医科学院作为龙头,以现有的中医药研究机构作为一个结点,形成国家省域的一个网络,更好地实现项目管理、资源配置、人事制度、科技评价等。

南京中医药大学副校长程海波认为,建设中医药特色科技创新体系,把握好研究方向非常重要。一方面是国家的重大需求,另一方面是中医药领域的重大科技。他认为,研究方向要反映中医药的特色和优势,如传承创新是很关键的问题,但往往被忽视,在一些研究工作中,常常抛开了中医药理论的指导,就医论医,就药论药。另外,科技创新体系建设要立足临床。中医药领域已经开展了一些临床研究工作,能否拿出一些国际公认的有效证据,值得关注。

那么,如何建设国家中医药创新体系?与会专家认为,分级分层可以实现统筹发展。第一个层面,让中医药平台能够进入国家级的实验室,进入国家层面的科技平台建设。第二个层面,国家中医药管理局层面争取得到财政部支持,进一步完善中医药科技创新体系。第三个层面,建设好省级层面的科技平台。第四个层面,高校、科研院所、医院和企业按照国家和省部相关的政策扶持要求,做好自身建设,促进符合中医药发展需要成果的产出等。(文/广东省中医院 宋莉萍)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1690012, encodeId=a9061690012d2, content=<a href='/topic/show?id=e963266341b' target=_blank style='color:#2F92EE;'>#体系建设#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26634, encryptionId=e963266341b, topicName=体系建设)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75d628947085, createdName=ms9203727104890838, createdTime=Fri Aug 31 09:25:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285606, encodeId=fef5128560601, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409621, encodeId=76a91409621a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617643, encodeId=6673161e6437a, content=<a href='/topic/show?id=9e9ce4939a5' target=_blank style='color:#2F92EE;'>#科技创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74939, encryptionId=9e9ce4939a5, topicName=科技创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2cf19789758, createdName=12498bf3m31暂无昵称, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1690012, encodeId=a9061690012d2, content=<a href='/topic/show?id=e963266341b' target=_blank style='color:#2F92EE;'>#体系建设#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26634, encryptionId=e963266341b, topicName=体系建设)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75d628947085, createdName=ms9203727104890838, createdTime=Fri Aug 31 09:25:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285606, encodeId=fef5128560601, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409621, encodeId=76a91409621a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617643, encodeId=6673161e6437a, content=<a href='/topic/show?id=9e9ce4939a5' target=_blank style='color:#2F92EE;'>#科技创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74939, encryptionId=9e9ce4939a5, topicName=科技创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2cf19789758, createdName=12498bf3m31暂无昵称, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1690012, encodeId=a9061690012d2, content=<a href='/topic/show?id=e963266341b' target=_blank style='color:#2F92EE;'>#体系建设#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26634, encryptionId=e963266341b, topicName=体系建设)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75d628947085, createdName=ms9203727104890838, createdTime=Fri Aug 31 09:25:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285606, encodeId=fef5128560601, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409621, encodeId=76a91409621a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617643, encodeId=6673161e6437a, content=<a href='/topic/show?id=9e9ce4939a5' target=_blank style='color:#2F92EE;'>#科技创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74939, encryptionId=9e9ce4939a5, topicName=科技创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2cf19789758, createdName=12498bf3m31暂无昵称, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=)]
    2018-07-11 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1690012, encodeId=a9061690012d2, content=<a href='/topic/show?id=e963266341b' target=_blank style='color:#2F92EE;'>#体系建设#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26634, encryptionId=e963266341b, topicName=体系建设)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75d628947085, createdName=ms9203727104890838, createdTime=Fri Aug 31 09:25:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285606, encodeId=fef5128560601, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409621, encodeId=76a91409621a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617643, encodeId=6673161e6437a, content=<a href='/topic/show?id=9e9ce4939a5' target=_blank style='color:#2F92EE;'>#科技创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74939, encryptionId=9e9ce4939a5, topicName=科技创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2cf19789758, createdName=12498bf3m31暂无昵称, createdTime=Wed Jul 11 07:25:00 CST 2018, time=2018-07-11, status=1, ipAttribution=)]

相关资讯

中医药科技创新明确九大任务

科技部、国家中医药管理局近日联合印发《“十三五”中医药科技创新专项规划》。《规划》提出,到2020年,建立更加协同、高效、开放的中医药科技创新体系,解决一批制约中医药发展的关键科学问题,突破一批制约中医药发展的关键核心技术,加速推进中医药现代化和国际化发展,构建更加符合中医药传承与创新特点的研究模式和技术体系,显着增强中医药科技创新能力。